Comparing albuvirtide plus ritonavir-boosted lopinavir regimen to two nucleotide reverse transcriptase inhibitors plus ritonavir-boosted lopinavir in HIV-infected individuals who failed initial treatment: a retrospective comparative cohort study.
Annals Of Translational Medicine
Chen, Liyu L; Dai, Hua H; Wang, Jiayi J; Wang, Ming M; Ma, Yuanji Y; Ma, Fanghua F; Li, Changmin C; Bai, Lang L; Du, Lingyao L; Tang, Hong H
Risk Factors of Drug Resistance and the Potential Risk of HIV-1 Transmission of Patients with ART Virological Failure: A Population-Based Study in Sichuan, China.
Infection And Drug Resistance
Zhou, Chang C; Kang, Rui R; Liang, Shu S; Fei, Teng T; Li, Yiping Y; Su, Ling L; Li, Ling L; Ye, Li L; Zhang, Yan Y; Yuan, Dan D
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
Biomed Research International
Chaves, Yury Oliveira YO; Pereira, Flávio Ribeiro FR; de Souza Pinheiro, Rebeca R; Batista, Diego Rafael Lima DRL; da Silva Balieiro, Antônio Alcirley AA; de Lacerda, Marcus Vinicius Guimarães MVG; Nogueira, Paulo Afonso PA; Guimarães, Monick Lindenmeyer ML
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial.
Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America
Orkin, Chloe C; Squires, Kathleen E KE; Molina, Jean-Michel JM; Sax, Paul E PE; Sussmann, Otto O; Lin, Gina G; Kumar, Sushma S; Hanna, George J GJ; Hwang, Carey C; Martin, Elizabeth E; Teppler, Hedy H
Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania.
Plos One
Mziray, Shabani Ramadhani SR; Kumburu, Happiness H HH; Assey, Hellen B HB; Sonda, Tolbert B TB; Mahande, Michael J MJ; Msuya, Sia E SE; Kiwelu, Ireen E IE
Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study.
Bmc Infectious Diseases
Yuan, Dan D; Liu, Meijing M; Jia, Peng P; Li, Yiping Y; Huang, Yuling Y; Ye, Li L; Api, Laze L; Chen, Maogang M; Yao, Liang L; Wang, Zixin Z; Liu, Honglu H; Liang, Shu S; Yang, Shujuan S
Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection.
Drugs In Context
Pham, Hanh Thi HT; Xiao, Meng A MA; Principe, Miguel Av MA; Wong, Alexander A; Mesplède, Thibault T
High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy.
Medicine
Deletsu, Selase D SD; Maina, Edward K EK; Quaye, Osbourne O; Ampofo, William K WK; Awandare, Gordon A GA; Bonney, Evelyn Y EY
HIV-1 acquired drug resistance to integrase inhibitors in a cohort of antiretroviral therapy multi-experienced Mexican patients failing to raltegravir: a cross-sectional study.
Aids Research And Therapy
Orta-Resendiz, Aurelio A; Rodriguez-Diaz, Roberto A RA; Angulo-Medina, Luis A LA; Hernandez-Flores, Mario M; Soto-Ramirez, Luis E LE
Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa.
Eclinicalmedicine
Villa, Giovanni G; Abdullahi, Adam A; Owusu, Dorcas D; Smith, Colette C; Azumah, Marilyn M; Sayeed, Laila L; Austin, Harrison H; Awuah, Dominic D; Beloukas, Apostolos A; Chadwick, David D; Phillips, Richard R; Geretti, Anna Maria AM
Evaluating an enhanced adherence intervention among HIV positive adolescents failing atazanavir/ritonavir-based second line antiretroviral treatment at a public health clinic.
Journal Of Aids And Hiv Research (Online)
Chawana, Tariro Dianah TD; Katzenstein, David D; Nathoo, Kusum K; Ngara, Bernard B; Nhachi, Charles Fungai Brian CFB
HIV Drug Resistance Mutations in Patients with HIV and HIV-TB Coinfection After Failure of First-Line Therapy: A Prevalence Study in a Resource-Limited Setting.
Journal Of The International Association Of Providers Of Aids Care
Khan, Nawaid Hussain NH; Kohli, Mikashmi M; Gupta, Kartik K; Das, Bimal Kumar BK; Pandey, Ravindra Mohan RM; Sinha, Sanjeev S
Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.
Journal Of Acquired Immune Deficiency Syndromes (1999)
Johnson, Margaret M; Kumar, Princy P; Molina, Jean-Michel JM; Rizzardini, Giuliano G; Cahn, Pedro P; Bickel, Markus M; Mallolas, Josep J; Zhou, Yan Y; Morais, Cristiana C; Kumar, Sushma S; Sklar, Peter P; Hanna, George J GJ; Hwang, Carey C; Greaves, Wayne W; ,
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America
Orkin, Chloe C; Squires, Kathleen E KE; Molina, Jean-Michel JM; Sax, Paul E PE; Wong, Wing-Wai WW; Sussmann, Otto O; Kaplan, Richard R; Lupinacci, Lisa L; Rodgers, Anthony A; Xu, Xia X; Lin, Gina G; Kumar, Sushma S; Sklar, Peter P; Nguyen, Bach-Yen BY; Hanna, George J GJ; Hwang, Carey C; Martin, Elizabeth A EA; ,
HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.
Aids (London, England)
Kantor, Rami R; DeLong, Allison A; Schreier, Leeann L; Reitsma, Marissa M; Kemboi, Emanuel E; Orido, Millicent M; Obonge, Salome S; Boinett, Robert R; Rono, Mary M; Emonyi, Wilfred W; Brooks, Katie K; Coetzer, Mia M; Buziba, Nathan N; Hogan, Joseph J; Diero, Lameck L
Human immunodeficiency virus type 1 drug resistance in a subset of mothers and their infants receiving antiretroviral treatment in Ouagadougou, Burkina Faso.
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring.
The Journal Of Antimicrobial Chemotherapy
Villa, Giovanni G; Phillips, Richard O RO; Smith, Colette C; Stockdale, Alexander J AJ; Ruggiero, Alessandra A; Beloukas, Apostolos A; Appiah, Lambert T LT; Chadwick, David D; Sarfo, Fred S FS; Geretti, Anna Maria AM
High Virologic Failure Rates with Maraviroc-Based Salvage Regimens Among Indian Patients: A Preliminary Analysis-Maraviroc Effectiveness in HIV-1 Subtype C.
Journal Of The International Association Of Providers Of Aids Care
Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda.
Aids Research And Human Retroviruses
Ndashimye, Emmanuel E; Avino, Mariano M; Kyeyune, Fred F; Nankya, Immaculate I; Gibson, Richard M RM; Nabulime, Eva E; Poon, Art F Y AFY; Kityo, Cissy C; Mugyenyi, Peter P; Quiñones-Mateu, Miguel E ME; Arts, Eric J EJ
Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: findings from a cross-sectional study.
Bmc Research Notes
Adawaye, Chatté C; Fokam, Joseph J; Kamangu, Erick E; Alio, Hamit Mahamat HM; Chahad, Aoudalkarim Moussa AM; Susin, Fabrice F; Moussa, Ali Mahamat AM; Bertin, Tchombou Hig-Zounet TH; Tidjani, Abdelsalam A; Vaira, Dolores D; Moutschen, Michel M
Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
Scientific Reports
Teto, Georges G; Tagny, Claude T CT; Mbanya, Dora D; Fonsah, Julius Y JY; Fokam, Joseph J; Nchindap, Emilienne E; Kenmogne, Léopoldine L; Njamnshi, Alfred K AK; Kanmogne, Georgette D GD
Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
Bmj Open
Kan, Wei W; Teng, Tao T; Liang, Shujia S; Ma, Yanling Y; Tang, Heng H; Zuohela, Tuerdi T; Sun, Guoqing G; He, Cui C; Wall, Kristin M KM; Marconi, Vincent C VC; Liao, Lingjie L; Leng, Xuebing X; Liu, Pengtao P; Ruan, Yuhua Y; Xing, Hui H; Shao, Yiming Y
Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.
Journal Of The International Aids Society
Moscona, Roy R; Ram, Daniela D; Wax, Marina M; Bucris, Efrat E; Levy, Itzchak I; Mendelson, Ella E; Mor, Orna O
Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.
Aids And Behavior
Ramadhani, Habib O HO; Muiruri, Charles C; Maro, Venance P VP; Nyombi, Balthazar B; Omondi, Michael M; Mushi, Julian B JB; Lirhunde, Eileen S ES; Bartlett, John A JA
Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.
Aids (London, England)
Muri, Lukas L; Gamell, Anna A; Ntamatungiro, Alex J AJ; Glass, Tracy R TR; Luwanda, Lameck B LB; Battegay, Manuel M; Furrer, Hansjakob H; Hatz, Christoph C; Tanner, Marcel M; Felger, Ingrid I; Klimkait, Thomas T; Letang, Emilio E; ,
HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.
Journal Of Acquired Immune Deficiency Syndromes (1999)
Samuel, Reshmi R; Julian, Marc Noguera MN; Paredes, Roger R; Parboosing, Raveen R; Moodley, Pravi P; Singh, Lavanya L; Naidoo, Anneta A; Gordon, Michelle M
Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.
Aids (London, England)
Casadellà, Maria M; Noguera-Julian, Marc M; Sunpath, Henry H; Gordon, Michelle M; Rodriguez, Cristina C; Parera, Mariona M; Kuritzkes, Daniel R DR; Marconi, Vincent C VC; Paredes, Roger R